Authors: Mazza, P Palazzo, G Amurri, B Pricolo, G Prudenzano, A Stani, L

Citation: P. Mazza et al., Rituximab with peripheral blood stem cell transplantation in CD20 lymphoproliferative disorders, HAEMATOLOG, 86(10), 2001, pp. 1104-1105

Authors: Mazza, P Amurri, B Palazzo, G Prudenzano, A Pricolo, G Stani, L

Citation: P. Mazza et al., Fludarabine-containing regimen followed by autologous peripheral blood stem cell transplantation in unselected patients with acute myeloid leukemia: a single center experience, HAEMATOLOG, 85(2), 2000, pp. 222-224

Authors: Mazza, P Palazzo, G Amurri, B Cervellera, M Rizzo, C Maggi, A

Citation: P. Mazza et al., Acute leukemia in Jehovah's Witnesses: a challenge for hematologists, HAEMATOLOG, 85(11), 2000, pp. 1221-1222

Authors: Mazza, P Secondo, E Palazzo, G Amurri, B Manna, N Miloro, G Moscogiuri, R

Citation: P. Mazza et al., Costs of high-dose salvage therapy and blood stem cell transplantation forresistant-relapsed malignant lymphomas in a Southern Italian hospital, HAEMATOLOG, 84(2), 1999, pp. 142-149

Authors: Mazza, P Palazzo, G Amurri, B Cervellera, M Manna, N Fellini, G Casulli, F Ghiggini, M Peluso, A Pricolo, G Prudenzano, A Stani, L

Citation: P. Mazza et al., Analysis of feasibility of myeloablative therapy and autologous peripheralstem cell (PBSC) transplantation in the elderly: an interim report, BONE MAR TR, 23(12), 1999, pp. 1273-1278

Authors: Manna, A Bacigalupo, A Palazzo, G Amurri, B Maggi, A Mazza, P

Citation: A. Manna et al., Successful one antigen mismatched bone marrow transplant for chronic myeloid leukemia (CML) after two failed syngeneic transplants, BONE MAR TR, 23(10), 1999, pp. 1085-1086